EDGAR Filing Documents for 0001564590-17-012795

Form 8-K - Current report:

SEC Accession No. 0001564590-17-012795

Filing Date

2017-06-21

Accepted

2017-06-21 16:05:19

Documents

Period of Report

2017-06-20

Items

Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ctmx-8k_20170621.htm	8-K	47264
	Complete submission text file	0001564590-17-012795.txt		48350

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 17922951
SIC: 2834 Pharmaceutical Preparations